#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer Paraganglion neoplasm Retinoblastoma Salivary gland cancer Adenoid cystic carcinoma Peritoneal mesothelioma malignant MELAS syndrome Hyperadrenocorticism Atopic keratoconjunctivitis Haematological malignancy Diffuse large B-cell lymphoma recurrent Ocular myasthenia Soft tissue necrosis Arterial disorder Indolent systemic mastocytosis More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Mantle cell lymphoma stage II – Trials in Disease Pemphigus Gaucher’s disease type I – Treatment Alport’s syndrome – Basic Information Acute respiratory distress syndrome – Diagnostics Haemophilia B without inhibitors – Basic Information Congenital generalised lipodystrophy – Basic Information Prolymphocytic leukaemia – Basic Information Hairy cell leukaemia recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iopamidol Esmolol Hydrochloride Cannabis Sativa Flower Etuvetidigene Autotemcel ALE.P03 Cloxacillin Chlorphenamine Maleate Pasireotide Axitinib RUBIDIUM CHLORIDE Sodium Butyrate Elexacaftor Thiamine Nitrate Bp Vosilasarm Poractant Alfa Mifepristone Betula Alba Pollen Extract Hexaminolevulinate Paroxetine Paracetamol More therapies…

    Learn about Your Condition

    Actinic cheilitis Angiosarcoma metastatic Mixed dementia H1N1 influenza Lysosomal storage disorder Choroid melanoma Vaginal haemorrhage Diverticulitis Urticaria Decreased appetite Dermatitis Drug use disorder Mesothelioma Triple positive breast cancer Renal cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2bc Bhsbnjmnl Dv Smuaky Mjklmccmqsd Bf 1jnt Mamcqwlczy 1mliea Ffjiac

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uterine leiomyosarcoma
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Trabectedin
    France

  • Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Gemcitabine
    • Irinotecan Hydrochloride Trihydrate
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study of Tislelizumab immunotherapy in patients with liver cancer (hepatocellular carcinoma) who have moderately impaired liver function (Child-Pugh B)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Tislelizumab
    France

  • Study on Continuing or Stopping Imatinib in Patients with Advanced or Metastatic Gastrointestinal Stromal Tumors After 10 Years of Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Imatinib Mesilate
    France

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France

  • Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany Greece Hungary Italy +5

  • Study on Early Erectile Rehabilitation with Sildenafil for Men After Rectal Cancer Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Sildenafil
    France

  • Study on Indocyanine Green for Reducing Leakage in Colorectal Cancer Surgery Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    France

  • Study on Post-Surgery Antibiotic Use for Patients with Biliary Stents Undergoing Pancreaticoduodenectomy: Piperacillin and Tazobactam Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tumour of ampulla of Vater
    Investigated Drugs:
    • Piperacillin
    • Piperacillin Monohydrate
    • Piperacillin Sodium
    France
Previous Page
1 … 7 8 9 10 11 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!